On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...
Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.
Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...
EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...
Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.
Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a record third quarter for medical cannabis revenue, net income, adjusted ...